The Effect of Time Window for Umbilical Cord Clamping During Cesareans on Offspring Hemoglobin and Maternal Blood Loss

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-22

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial, aiming to evaluate the effects of time window for umbilical cord clamping during cesarean section on the health outcomes of offspring hemoglobin，maternal blood loss，and children's growth and development. It will be conducted in Liuyang city and Huantai county of China, and the targeted sample size is 360 (180 in each site). All the eligible pregnant women will be randomly assigned to one of the four groups (three intervention groups and one control group), and their babies will be followed up to 18 months of age.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Delayed Cord Clamping in Infants Born by Cesarean Section

NCT03549884

Umbilical Cord Management Elective Cesarean Section

COMPLETED NA

Delayed Cord Clamping at Term Cesarean

NCT03150641

Maternal Blood Loss Cesarean Delivery Delayed Cord Clamping +1 more

COMPLETED NA

Effect of Umbilical Cord Milking on Iron Related Health Outcomes for Cesarean-Delivered Infants

NCT02892461

Anemia, Iron-Deficiency

COMPLETED NA

Intact-cord Stabilisation and Physiology-based Cord Clamping in Caesarean Sections

NCT05461950

Cesarean Section Infant Conditions

COMPLETED

Milking the Umbilical Cord at Term Cesarean Birth

NCT01630993

Anemia

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The World Health Organization and American College of Obstetricians and Gynecologists have recommended a delay in umbilical cord clamping after birth, irrespective of delivery modes, which was based on studies from vaginal deliveries rather than cesareans. In cesareans, the optimal time window for umbilical cord clamping has not been determined, and the relevant safety data are limited. In this randomized study, the investigators aim to evaluate the impacts of time window for umbilical cord clamping during cesarean section on maternal and child health outcomes, and to evaluate the optimal timing of the clamping. The investigators are planning to enroll 360 pregnant women scheduled for cesareans, and to randomly allocate them into four groups: the umbilical cord will be clamped within 15 seconds (immediately), or delayed after deliveries for 30, 60, and 90 seconds, respectively. Babies will be followed up at 3, 6, 12, and 18 months of age. Maternal hemoglobin before and after cesareans, neonatal hemoglobin, children's hemoglobin at 6, 12, 18 months of age will be measured. At each follow-up visit, children's length and weight will be measured, their development will be assessed, and a questionnaire survey including information on feeding, sleep, and medication will be conducted. The primary outcomes are the neonatal hemoglobin and the change in maternal hemoglobin. The secondary outcomes include the incidence rate of neonatal anemia and jaundice, Apgar score, the incidence rate of neonatal intensive care unit (NICU) admission, placental weight, maternal hemoglobin after the cesarean, estimated maternal blood loss, and the incidence rate of maternal blood transfusion. In addition, the children's hemoglobin, anemia, growth and development are considered as the exploratory secondary outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delayed Cord Clamping Hemoglobin Blood Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Delay 30s group

Cord clamping will be delayed at 30 seconds after delivery.

Group Type EXPERIMENTAL

Delayed cord clamping (30s)

Intervention Type PROCEDURE

The same as that stated in arm descriptions.

Delay 60s group

Cord clamping will be delayed at 60 seconds after delivery.

Group Type EXPERIMENTAL

Delayed cord clamping (60s)

Intervention Type PROCEDURE

The same as that stated in arm descriptions.

Delay 90s group

Cord clamping will be delayed at 90 seconds after delivery.

Group Type EXPERIMENTAL

Delayed cord clamping (90s)

Intervention Type PROCEDURE

The same as that stated in arm descriptions.

Control group

Cord clamping will be immediate (within 15 seconds) after delivery, in accordance with the standard practice in the study sites

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delayed cord clamping (30s)

The same as that stated in arm descriptions.

Intervention Type PROCEDURE

Delayed cord clamping (60s)

The same as that stated in arm descriptions.

Intervention Type PROCEDURE

Delayed cord clamping (90s)

The same as that stated in arm descriptions.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* local resident in Liuyang city, Huantai county and their surrounding areas
* Singleton pregnancy
* Elective caesarean, or cesarean section after the start of labor but the cervix is less than 3 cm
* Term pregnancy (≥37 weeks of gestation), and the fetal weight was estimated ≥2500g by intrauterine ultrasound
* Written informed consent is obtained

Exclusion Criteria

* Pregnant women with the following risk factors: severe hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥110mmHg), preeclampsia, chronic hypertension with preeclampsia, diabetes mellitus with severe microangiopathy, placenta previa, placenta implantation, placental abruption, intrauterine distress, prenatal infection, severe anemia (hemoglobin\<7g/dL), coagulation disorders, thrombosis disease
* Plan to retain cord blood
* Rh-negative pregnant women
* Prenatal diagnosis of fetal abnormalities which may lead to difficulties in cesareans or adverse pregnancy outcomes, such as abnormal heart monitoring, fetal distress, malformation, anemia, and intrauterine growth restrictions
* Other conditions not suitable for intervention as judged by obstetricians

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes